OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 35 citing articles:

Drug resistance in epilepsy
Emilio Perucca, Piero Perucca, H. Steve White, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 8, pp. 723-734
Closed Access | Times Cited: 103

Neuroinflammatory mediators in acquired epilepsy: an update
Yu Chen, Marwa M. Nagib, Nelufar Yasmen, et al.
Inflammation Research (2023) Vol. 72, Iss. 4, pp. 683-701
Open Access | Times Cited: 59

mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment
Teresa Ravizza, Mirte Scheper, Rossella Di Sapia, et al.
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 5, pp. 334-350
Closed Access | Times Cited: 28

Insights into epileptogenesis from post-traumatic epilepsy
Matthew Pease, Kunal Gupta, Solomon L. Moshé, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 5, pp. 298-312
Closed Access | Times Cited: 19

The pharmacological treatment of epilepsy: recent advances and future perspectives
Emilio Perucca
Acta Epileptologica (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 62

Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy
Eleonora Aronica, Nicola Specchio, Mark J. Luinenburg, et al.
Brain (2023) Vol. 146, Iss. 7, pp. 2694-2710
Open Access | Times Cited: 37

Which terms should be used to describe medications used in the treatment of seizure disorders? An ILAE position paper
Emilio Perucca, Jacqueline A. French, Ghaieb Aljandeel, et al.
Epilepsia (2024) Vol. 65, Iss. 3, pp. 533-541
Open Access | Times Cited: 12

The expanding field of genetic developmental and epileptic encephalopathies: current understanding and future perspectives
Nicola Specchio, Marina Trivisano, Eleonora Aronica, et al.
The Lancet Child & Adolescent Health (2024) Vol. 8, Iss. 11, pp. 821-834
Closed Access | Times Cited: 6

Antiepileptogenesis after stroke—trials and tribulations: Methodological challenges and recruitment results of a Phase II study with eslicarbazepine acetate
Matthias J. Koepp, Eugen Trinka, Yee‐Haur Mah, et al.
Epilepsia Open (2023) Vol. 8, Iss. 3, pp. 1190-1201
Open Access | Times Cited: 15

Antiepileptogenesis and disease modification: Clinical and regulatory issues
Jacqueline A. French, Martina Bebin, Marc A. Dichter, et al.
Epilepsia Open (2021) Vol. 6, Iss. 3, pp. 483-492
Open Access | Times Cited: 29

A complex systems view on the current hypotheses of epilepsy pharmacoresistance
Gabriel Servilha‐Menezes, Norberto Garcia‐Cairasco
Epilepsia Open (2022) Vol. 7, Iss. S1
Open Access | Times Cited: 20

Revisiting the concept of drug‐resistant epilepsy: A TASK1 report of the ILAE/AES Joint Translational Task Force
Stéphane Auvin, Aristea S. Galanopoulou, Solomon L. Moshé, et al.
Epilepsia (2023) Vol. 64, Iss. 11, pp. 2891-2908
Closed Access | Times Cited: 12

Pharmacologically targeting transient receptor potential channels for seizures and epilepsy: Emerging preclinical evidence of druggability
Jianxiong Jiang, Ying Yu
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108384-108384
Open Access | Times Cited: 11

TRPV1 channel in the pathophysiology of epilepsy and its potential as a molecular target for the development of new antiseizure drug candidates
Katarzyna Socała, Marcin Jakubiec, Michał Abram, et al.
Progress in Neurobiology (2024) Vol. 240, pp. 102634-102634
Open Access | Times Cited: 4

Recent Developments in Autism Genetic Research: A Scientometric Review from 2018 to 2022
Mengyu Lim, Alessandro Carollo, Dagmara Dimitriou, et al.
Genes (2022) Vol. 13, Iss. 9, pp. 1646-1646
Open Access | Times Cited: 17

Canonical Wnt activator Chir99021 prevents epileptogenesis in the intrahippocampal kainate mouse model of temporal lobe epilepsy
Muriel D. Mardones, Kevin D. Rostam, Margaret C. Nickerson, et al.
Experimental Neurology (2024) Vol. 376, pp. 114767-114767
Closed Access | Times Cited: 3

TRPC channels as emerging targets for seizure disorders
Ying Yu, Wěi Li, Jianxiong Jiang
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 9, pp. 787-798
Open Access | Times Cited: 14

Transgenic Mouse Overexpressing Spermine Oxidase in Cerebrocortical Neurons: Astrocyte Dysfunction and Susceptibility to Epileptic Seizures
Manuela Marcoli, Chiara Cervetto, Sarah Amato, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 204-204
Open Access | Times Cited: 11

Editorial: Neuroinflammation in acquired epilepsy
Jianxiong Jiang, Vijayalakshmi Santhakumar, Xinjian Zhu
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 10

(+)-Borneol exerts neuroprotective effects via suppressing the NF-κB pathway in the pilocarpine-induced epileptogenesis rat model
Fankai Gao, Rui Chen, Shuo Li, et al.
Brain Research (2023) Vol. 1810, pp. 148382-148382
Closed Access | Times Cited: 6

Microglial activation and over pruning involved in developmental epilepsy
Qiong Wu, Hua Wang, Xueyan Liu, et al.
Journal of Neuropathology & Experimental Neurology (2022) Vol. 82, Iss. 2, pp. 150-159
Closed Access | Times Cited: 8

Effect of dietary supplementation with Lactobacillus helveticus R0052 on seizure thresholds and antiseizure potency of sodium valproate in mice
Piotr Właź, Adrian Wiater, Małgorzata Majewska, et al.
Psychopharmacology (2023) Vol. 241, Iss. 2, pp. 327-340
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top